Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation: Two Case Reports.
about
Targeted Lung Cancer Treatments and Eye MetastasisPreclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System.Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer.Non-small cell lung cancer leptomeningeal metastases treated with intrathecal therapy plus osimertinib and temozolomide and whole-brain radiation therapy: a case report
P2860
Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation: Two Case Reports.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rapid intracranial response to ...... 0M mutation: Two Case Reports.
@en
Rapid intracranial response to ...... 0M mutation: Two Case Reports.
@nl
type
label
Rapid intracranial response to ...... 0M mutation: Two Case Reports.
@en
Rapid intracranial response to ...... 0M mutation: Two Case Reports.
@nl
prefLabel
Rapid intracranial response to ...... 0M mutation: Two Case Reports.
@en
Rapid intracranial response to ...... 0M mutation: Two Case Reports.
@nl
P2093
P2860
P1433
P1476
Rapid intracranial response to ...... 0M mutation: Two Case Reports.
@en
P2093
Atsushi Kumanogoh
Haruhiko Hirata
Hiroshi Kida
Izumi Nagatomo
Masanari Hamaguchi
Muneyoshi Kuroyama
Takashi Kijima
Takayuki Takimoto
Tomoyuki Otsuka
P2860
P356
10.1097/MD.0000000000006087
P407
P577
2017-02-01T00:00:00Z